The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).
Maria Grazia Ghi
No relevant relationships to disclose
Adriano Paccagnella
No relevant relationships to disclose
Daris Ferrari
No relevant relationships to disclose
Paolo Foa
No relevant relationships to disclose
Maria Cossu Rocca
No relevant relationships to disclose
Elena Verri
No relevant relationships to disclose
Franco Morelli
No relevant relationships to disclose
Giuseppe Azzarello
No relevant relationships to disclose
Consuelo D'Ambrosio
No relevant relationships to disclose
Giorgio Cruciani
No relevant relationships to disclose
Monica Guaraldi
No relevant relationships to disclose
Elena Massa
No relevant relationships to disclose
Ciro Rossetto
No relevant relationships to disclose
Andrea Bonetti
No relevant relationships to disclose
Salvatore Siena
No relevant relationships to disclose
Vincenzo Minotti
No relevant relationships to disclose
Haralabos Koussis
No relevant relationships to disclose
Gabriella Pieri
No relevant relationships to disclose
Vittorio Baggio
No relevant relationships to disclose
Irene Floriani
No relevant relationships to disclose